Cargando…

Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes

BACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavvoura, Fotini K., Raimondo, Anne, Thanabalasingham, Gayathiry, Barrett, Amy, Webster, Amanda L., Shears, Debbie, Mann, Nicholas P., Ellard, Sian, Gloyn, Anna L., Owen, Katharine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186945/
https://www.ncbi.nlm.nih.gov/pubmed/24606082
http://dx.doi.org/10.1210/jc.2013-3641
_version_ 1782338133758574592
author Kavvoura, Fotini K.
Raimondo, Anne
Thanabalasingham, Gayathiry
Barrett, Amy
Webster, Amanda L.
Shears, Debbie
Mann, Nicholas P.
Ellard, Sian
Gloyn, Anna L.
Owen, Katharine R.
author_facet Kavvoura, Fotini K.
Raimondo, Anne
Thanabalasingham, Gayathiry
Barrett, Amy
Webster, Amanda L.
Shears, Debbie
Mann, Nicholas P.
Ellard, Sian
Gloyn, Anna L.
Owen, Katharine R.
author_sort Kavvoura, Fotini K.
collection PubMed
description BACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigations leads to the correct classification of diabetes etiology. CASE DISCUSSION: A 30-year-old European female was diagnosed with insulin-treated gestational diabetes. She discontinued insulin after delivery; however, her fasting hyperglycemia persisted. β-Cell antibodies were negative and C-peptide was 0.79 nmol/L. Glucokinase (GCK)-MODY was suspected and confirmed by the identification of a GCK mutation (p.T206M). METHODS: Systematic clinical and biochemical characterization and GCK mutational analysis were implemented to determine the diabetes etiology in five relatives. Functional characterization of GCK mutations was performed. RESULTS: Identification of the p.T206M mutation in the proband's sister confirmed a diagnosis of GCK-MODY. Her daughter was diagnosed at 16 weeks with permanent neonatal diabetes (PNDM). Mutation analysis identified two GCK mutations that were inherited in trans-p. [(R43P);(T206M)], confirming a diagnosis of GCK-PNDM. Both mutations were shown to be kinetically inactivating. The proband's mother, other sister, and daughter all had a clinical diagnosis of type 1 diabetes, confirmed by undetectable C-peptide levels and β-cell antibody positivity. GCK mutations were not detected. CONCLUSIONS: Two previously misclassified family members were shown to have GCK-MODY, whereas another was shown to have GCK-PNDM. A diagnosis of type 1 diabetes was confirmed in three relatives. This family exemplifies the importance of careful phenotyping and systematic evaluation of relatives after discovering monogenic diabetes in an individual.
format Online
Article
Text
id pubmed-4186945
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-41869452014-10-10 Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes Kavvoura, Fotini K. Raimondo, Anne Thanabalasingham, Gayathiry Barrett, Amy Webster, Amanda L. Shears, Debbie Mann, Nicholas P. Ellard, Sian Gloyn, Anna L. Owen, Katharine R. J Clin Endocrinol Metab JCEM Online: Brief Reports BACKGROUND: Maturity-onset diabetes of the young (MODY) is uncommon; however, accurate diagnosis facilitates personalized management and informs prognosis in probands and relatives. OBJECTIVE: The objective of the study was to highlight that the appropriate use of genetic and nongenetic investigations leads to the correct classification of diabetes etiology. CASE DISCUSSION: A 30-year-old European female was diagnosed with insulin-treated gestational diabetes. She discontinued insulin after delivery; however, her fasting hyperglycemia persisted. β-Cell antibodies were negative and C-peptide was 0.79 nmol/L. Glucokinase (GCK)-MODY was suspected and confirmed by the identification of a GCK mutation (p.T206M). METHODS: Systematic clinical and biochemical characterization and GCK mutational analysis were implemented to determine the diabetes etiology in five relatives. Functional characterization of GCK mutations was performed. RESULTS: Identification of the p.T206M mutation in the proband's sister confirmed a diagnosis of GCK-MODY. Her daughter was diagnosed at 16 weeks with permanent neonatal diabetes (PNDM). Mutation analysis identified two GCK mutations that were inherited in trans-p. [(R43P);(T206M)], confirming a diagnosis of GCK-PNDM. Both mutations were shown to be kinetically inactivating. The proband's mother, other sister, and daughter all had a clinical diagnosis of type 1 diabetes, confirmed by undetectable C-peptide levels and β-cell antibody positivity. GCK mutations were not detected. CONCLUSIONS: Two previously misclassified family members were shown to have GCK-MODY, whereas another was shown to have GCK-PNDM. A diagnosis of type 1 diabetes was confirmed in three relatives. This family exemplifies the importance of careful phenotyping and systematic evaluation of relatives after discovering monogenic diabetes in an individual. Endocrine Society 2014-06 2014-02-27 /pmc/articles/PMC4186945/ /pubmed/24606082 http://dx.doi.org/10.1210/jc.2013-3641 Text en Copyright © 2014 by the Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/us/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle JCEM Online: Brief Reports
Kavvoura, Fotini K.
Raimondo, Anne
Thanabalasingham, Gayathiry
Barrett, Amy
Webster, Amanda L.
Shears, Debbie
Mann, Nicholas P.
Ellard, Sian
Gloyn, Anna L.
Owen, Katharine R.
Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title_full Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title_fullStr Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title_full_unstemmed Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title_short Reclassification of Diabetes Etiology in a Family With Multiple Diabetes Phenotypes
title_sort reclassification of diabetes etiology in a family with multiple diabetes phenotypes
topic JCEM Online: Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186945/
https://www.ncbi.nlm.nih.gov/pubmed/24606082
http://dx.doi.org/10.1210/jc.2013-3641
work_keys_str_mv AT kavvourafotinik reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT raimondoanne reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT thanabalasinghamgayathiry reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT barrettamy reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT websteramandal reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT shearsdebbie reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT mannnicholasp reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT ellardsian reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT gloynannal reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes
AT owenkathariner reclassificationofdiabetesetiologyinafamilywithmultiplediabetesphenotypes